Beta-adrenergic receptor — Drug Target
All drugs that target Beta-adrenergic receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Beta-blocker · Prostaglandin analogue and beta-adrenergic receptor blocker
Phase 3 pipeline (2)
- ARM B: Blocks Therapy Drug · Grupo Argentino de Tratamiento de la Leucemia Aguda · Beta-blocker · Oncology
ARM B: Blocks Therapy Drug inhibits beta-adrenergic receptors to reduce sympathetic nervous system activity in acute leukemia treatment. - unfixed Latanoprost and Timolol · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Prostaglandin analogue and beta-adrenergic receptor blocker · Ophthalmology
Latanoprost is a prostaglandin analogue that reduces intraocular pressure by increasing uveoscleral outflow, while Timolol is a beta-adrenergic receptor blocker that reduces intraocular pressure by decreasing aqueous humor production.